VanEck Biotech ETF (BBH)

NASDAQ: BBH · IEX Real-Time Price · USD
153.01
-0.91 (-0.59%)
Apr 17, 2024, 4:00 PM EDT - Market closed
-0.59%
Assets $424.52M
Expense Ratio 0.35%
PE Ratio 15.49
Shares Out 2.70M
Dividend (ttm) $0.71
Dividend Yield 0.47%
Ex-Dividend Date Dec 18, 2023
Payout Ratio 7.22%
1-Year Return -7.13%
Volume 9,505
Open 154.31
Previous Close 153.91
Day's Range 152.97 - 154.31
52-Week Low 142.51
52-Week High 171.05
Beta 0.83
Holdings 27
Inception Date Dec 20, 2011

About BBH

Fund Home Page

The VanEck Biotech ETF (BBH) is an exchange-traded fund that is based on the MVIS US Listed Biotech 25 index, a market-cap-weighted index of the 25 largest biotech firms globally. BBH was launched on Dec 20, 2011 and is issued by VanEck.

Asset Class Equity
Category Health
Region North America
Stock Exchange NASDAQ
Ticker Symbol BBH
ETF Provider VanEck
Index Tracked MVIS US Listed Biotech 25

Top 10 Holdings

67.97% of assets
Name Symbol Weight
Amgen Inc. AMGN 14.96%
Vertex Pharmaceuticals Incorporated VRTX 9.59%
Gilead Sciences, Inc. GILD 8.01%
Regeneron Pharmaceuticals, Inc. REGN 7.77%
Moderna, Inc. MRNA 5.65%
IQVIA Holdings Inc. IQV 4.83%
argenx SE ARGX 4.50%
Biogen Inc. BIIB 4.31%
ICON PLC ICLR 4.21%
Illumina, Inc. ILMN 4.14%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Dec 18, 2023 $0.7127 Dec 22, 2023
Dec 19, 2022 $0.7488 Dec 23, 2022
Dec 20, 2021 $0.3972 Dec 27, 2021
Dec 21, 2020 $0.6079 Dec 28, 2020
Dec 23, 2019 $0.4724 Dec 30, 2019
Dec 20, 2018 $0.551 Dec 27, 2018
Full Dividend History

News

VanEck Announces Year-End Distributions for VanEck Equity ETFs

NEW YORK--(BUSINESS WIRE)--VanEck announced today the 2023 annual distributions per share for its VanEck® equity exchange-traded funds.

4 months ago - Business Wire

Brown Brothers Harriman Private Banking Team Expands in Philadelphia

PHILADELPHIA--(BUSINESS WIRE)--The Private Banking arm of Brown Brothers Harriman & Co. (BBH) is pleased to announce the expansion and strengthening of its Corporate Advisory and Banking team in Phi...

1 year ago - Business Wire

VanEck Announces Yearend Distributions for VanEck Equity ETFs

NEW YORK--(BUSINESS WIRE)--VanEck announced today the following 2022 annual distributions per share for its VanEck® equity exchange-traded funds.

1 year ago - Business Wire

9 Best Biotech ETFs to Play High-Octane Trends

Biotechnology is a dynamic but often volatile industry. These biotech ETFs provide a lower-risk way to invest in the space.

3 years ago - Kiplinger

5 Top ETFs With Exposure To Biogen

For the first time in 18 years, there was a new treatment for Alzheimer's Disease approved by the FDA. Aducanumab from Biogen Inc (NASDAQ: BIIB) was approved as a drug that can reduce the clinical dec...

Other symbols: BIIBFBTIBBPBEPKW
3 years ago - Benzinga

3 ETFs For AstraZeneca's $39B Alexion Pharmaceuticals Takeover

The biotechnology space is always fertile territory for mergers and acquisitions, and that theme was on display over the weekend when AstraZeneca (NYSE: AZN) announced a $39-billion takeover of Alexio...

Other symbols: FBTPBE
3 years ago - Benzinga

Biotech ETFs at multi-week highs, extending winning streak

Biotechnology exchange-traded funds outperformed Tuesday as investors focused on next-generation solutions to the coronavirus and more. The ARK Genomic Revolution ETF was up 2.2% in the early afternoo...

Other symbols: FBTIBBXBI
3 years ago - Market Watch

A Divergence Has Occurred In Healthcare

For the first four months of the market’s cornavirus recovery, one of the key themes was the dominance of biotech.

Other symbols: PPH
3 years ago - Benzinga

Coronavirus treatment: FDA authorizes convalescent plasma for COVID-19 use

Yahoo Finance's Anjalee Khemlani reports on the FDA's approval on the use of convalescent plasma to treat COVID-19.

Other symbols: IBBXBI
3 years ago - Yahoo Finance